Channel Therapeutics Statistics
Total Valuation
CHRO has a market cap or net worth of $8.30 million. The enterprise value is $9.97 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CHRO has 6.10 million shares outstanding. The number of shares has increased by 336.69% in one year.
| Current Share Class | 6.10M |
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | +336.69% |
| Shares Change (QoQ) | +4.22% |
| Owned by Insiders (%) | 9.04% |
| Owned by Institutions (%) | 1.15% |
| Float | 2.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -3.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34
| Current Ratio | 0.34 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -645.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 278.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$723,213 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -18.47% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 1.12 |
| Relative Strength Index (RSI) | 46.38 |
| Average Volume (20 Days) | 2,058,151 |
Short Selling Information
The latest short interest is 9,126, so 0.15% of the outstanding shares have been sold short.
| Short Interest | 9,126 |
| Short Previous Month | 9,106 |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 1.64 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.57M |
| Pretax Income | -8.98M |
| Net Income | -7.96M |
| EBITDA | n/a |
| EBIT | -7.57M |
| Earnings Per Share (EPS) | -$1.43 |
Full Income StatementBalance Sheet
The company has $513,443 in cash and $2.19 million in debt, giving a net cash position of -$1.67 million or -$0.27 per share.
| Cash & Cash Equivalents | 513,443 |
| Total Debt | 2.19M |
| Net Cash | -1.67M |
| Net Cash Per Share | -$0.27 |
| Equity (Book Value) | -2.71M |
| Book Value Per Share | -0.44 |
| Working Capital | -2.71M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |